Dhanesh Amarnani

Dhanesh Amarnani

Auto-generated profile, based on publicly available information

Dhanesh Amarnani

Department of Ophthalmology at Harvard Medical School Schepens Eye Research Institute of Mass Eye and Ear 20 Staniford Street 02114 02114 Boston Boston Massachusetts MA USA USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AMArturo I. Machuca-Parra
Arturo I. Machuca-Parra
ABAlexander A. Bigger-Allen
Alexander A. Bigger-Allen
ASAngie V. Sanchez
Angie V. Sanchez
ABAnissa Boutabla
Anissa Boutabla
JCJonathan Cardona-Vélez
Jonathan Cardona-Vélez
JAJoseph F. Arboleda-Velasquez
Joseph F. Arboleda-Velasquez
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a neurological syndrome characterized by small vessel disease (SVD), stroke, and vascular cognitive impairment and dementia caused by mutations in NOTCH3. No therapies are available for this condition. Loss of mural cells, which encompass pericytes and vascular smooth muscle cells, is a hallmark of CADASIL and other SVDs, including diabetic retinopathy, resulting in vascular instability. Here, we showed that Notch3 signaling is both necessary and sufficient to support mural cell coverage in arteries using genetic rescue in Notch3 knockout mice. Furthermore, we show that systemic administration of an agonist Notch3 antibody prevents mural cell loss and modifies plasma proteins associated with Notch3 activity, including endostatin/collagen 18α1 and Notch3 extracellular domain in mice with the C455R mutation, a CADASIL variant associated with Notch3 loss of function. These findings open opportunities for the treatment of CADASIL and other SVDs by modulating Notch3 signaling.

1 July 2021 in The American Journal of Pathology
Verified
Journal Article
Closed access
MOMichael O'HAre
Michael O'HAre
DADhanesh Amarnani
Dhanesh Amarnani
HWHannah A.B. Whitmore
Hannah A.B. Whitmore
MAMiranda An
Miranda An
CMClaudia Marino
Claudia Marino
LKLeo A. Kim
Leo A. Kim

17 December 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
LGLucia Gonzalez-Buendia
Lucia Gonzalez-Buendia
SDSantiago Delgado-Tirado
Santiago Delgado-Tirado
MAMiranda An
Miranda An
MOMichael O'HAre
Michael O'HAre
DADhanesh Amarnani
Dhanesh Amarnani
LKLeo A. Kim
Leo A. Kim

1 May 2025
Verified
Journal Article
Open access
PDF file
DADhanesh Amarnani
Dhanesh Amarnani
EKEric J. Kim
Eric J. Kim
BDBrandon V. Duffy
Brandon V. Duffy
LRLeslie Ramos
Leslie Ramos
LKLeo A. Kim
Leo A. Kim
Purpose: To investigate the mechanism of chloroquine-induced cell death in vitro in adult human retinal pigmented epithelial (ARPE-19) cells and murine 661W photoreceptor-derived cells and to evaluate a mouse model of acute chloroquine-induced retinal toxicity. Methods: Human RPE cells and photoreceptor cells were cultured in vitro and treated with chloroquine; cell death was measured by lactate dehydrogenase release. Lysosomal-associated membrane protein-1 (LAMP-1) staining assessed lysosomal destabilization upstream of cell death initiation. The role of cathepsins, lysosomal proteases was examined by blocking their activity. Cell permeable caspase, and RIP1 kinase inhibitors were used to elucidate the role of downstream mediators of cell death signaling pathways. Adult mice were administered intravitreal injections of 50 micrograms of chloroquine. Fundus photography, optical coherence tomography, and electroretinography were used to evaluate drug-induced retinal changes after one week. Quantitative RT-PCR was used to evaluate changes in gene expression in mice retinal-pigmented epithelium and neurosensory retina. Results: ARPE-19 and 661W cells showed cell death within 24 hours of treatment. LAMP-1 staining and inhibition of cathepsins B, D, and L activity in ARPE-19 cells significantly decreased cell death, indicating that lysosomal destabilization and cathepsin release occur prior to regulated cell death. Treatment of RPE cells with caspase inhibitors and Nec-1 showed primarily caspase-dependent cell death in RPE cells whereas treatment of photoreceptor cells with caspase inhibitors and Nec-1 showed significant rescue of cell death. Chloroquine-injected animals demonstrated functional visual loss consistent with marked abnormality and disruption of the photoreceptor layer. Gene expression changes showed a significant up regulation of markers specific to caspase mediated cell death in the RPE and necrosis and oxidative stress markers in the neurosensory retina. Conclusions: ARPE-19 cells underwent both apoptotic and pyroptotic cell death while 661W cells showed activation of apoptosis and necroptosis. Chloroquine-injected mice demonstrated characteristic phenotypes also observed in human patients with chloroquine toxicity and showed activation of various cell death mediators. By elucidating the mechanism of chloroquine toxicity, we believe our findings can shed light on potential therapeutic agents.